Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Ritchie

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
European Journal of Medicinal Chemistry|August 2, 2008
Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SARVictor Andrianov, Vija Gailite, Daina Lola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2016
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed GlioblastomaRoy Rampling, Sharon Peoples, Paul J Mulholland, et al.
Nature Reviews. Clinical Oncology|December 6, 2018
A framework for the development of effective anti-metastatic agentsRobin L Anderson, Theo Balasas, Juliana Callaghan, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
European Journal of Medicinal Chemistry|August 2, 2008
Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SARVictor Andrianov, Vija Gailite, Daina Lola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2016
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed GlioblastomaRoy Rampling, Sharon Peoples, Paul J Mulholland, et al.
Nature Reviews. Clinical Oncology|December 6, 2018
A framework for the development of effective anti-metastatic agentsRobin L Anderson, Theo Balasas, Juliana Callaghan, et al.
Pageof 3